Natixis Investment Managers International - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 52 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Natixis Investment Managers International ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2018$425,000
+8.1%
4000.0%0.02%
-9.1%
Q2 2018$393,000
-1.3%
4000.0%0.02%
-21.4%
Q1 2018$398,000
-6.4%
4000.0%0.03%
-40.4%
Q4 2017$425,0004000.05%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2018
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders